GLUE Smart Money
Monte Rosa Therapeutics, Inc.
1W: -6.2%
1M: -9.0%
3M: -50.6%
YTD: -30.4%
1Y: -4.3%
3Y: +289.1%
5Y: -52.8%
$10.66
+0.18 (+1.72%)
Weekly Expected Move ±9.1%
$9
$10
$11
$12
$13
Credit Risk of going bust: higher than 56% of companies Debt: 4.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.08 (down 99.3%), Monte Rosa Therapeutics, Inc. would be worth roughly what it owes.
Total debt $38.0M against a stock market value of $909.4M.
Distance to default 4.57 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $21.3M (short-term plus half of long-term), stock volatility 78.8%; Altman Z'' 3.56. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.08 (down 99.3%), Monte Rosa Therapeutics, Inc. would be worth roughly what it owes.
Total debt $38.0M against a stock market value of $909.4M.
Distance to default 4.57 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $21.3M (short-term plus half of long-term), stock volatility 78.8%; Altman Z'' 3.56. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026219
Institutions Holding
+9 vs prior
224.5%
Ownership
+79.57%
30
New
80
Increased
82
Reduced
23
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Bowen Matthew | officer: principal accounting officer | S-Sale | 13 | $10.56 | $137 | Filing |
| 2026-07-16 | Warmuth Markus | officer: president & ceo | S-Sale | 9,500 | $23.18 | $220K | Filing |
| 2026-07-15 | Champoux Jennifer | officer: chief operating officer | S-Sale | 4,351 | $23.38 | $102K | Filing |
| 2026-07-06 | Townson Sharon | officer: chief scientific officer | S-Sale | 400 | $24.13 | $10K | Filing |
| 2026-07-06 | Townson Sharon | officer: chief scientific officer | S-Sale | 5,600 | $23.25 | $130K | Filing |
| 2026-07-01 | Behbahani Ali | director | J-J | 15,000 | $— | $0 | Filing |
| 2026-07-01 | Behbahani Ali | director | J-J | 1,000,000 | $— | $0 | Filing |
| 2026-06-30 | Janku Filip | officer: chief medical officer | S-Sale | 5,407 | $24.50 | $132K | Filing |
| 2026-06-29 | Janku Filip | officer: chief medical officer | S-Sale | 6,000 | $22.95 | $138K | Filing |
| 2026-06-29 | Manning Anthony M. | director | S-Sale | 10,000 | $23.11 | $231K | Filing |
| 2026-06-24 | Janku Filip | officer: chief medical officer | S-Sale | 30,000 | $21.42 | $643K | Filing |
| 2026-06-23 | Champoux Jennifer | officer: chief operating officer | S-Sale | 2,175 | $20.00 | $44K | Filing |
| 2026-06-23 | Townson Sharon | officer: chief scientific officer | S-Sale | 3,000 | $20.00 | $60K | Filing |
| 2026-06-23 | Janku Filip | officer: chief medical officer | S-Sale | 11,845 | $20.22 | $240K | Filing |
| 2026-06-17 | Townson Sharon | officer: chief scientific officer | S-Sale | 3,000 | $19.00 | $57K | Filing |
| 2026-06-17 | Champoux Jennifer | officer: chief operating officer | S-Sale | 2,176 | $19.00 | $41K | Filing |
| 2026-06-01 | Warmuth Markus | officer: president & ceo | S-Sale | 468 | $19.73 | $9K | Filing |
| 2026-06-01 | Warmuth Markus | officer: president & ceo | S-Sale | 4,998 | $19.41 | $97K | Filing |
| 2026-05-29 | Townson Sharon | officer: chief scientific officer | S-Sale | 6,000 | $19.87 | $119K | Filing |
| 2026-05-27 | Champoux Jennifer | officer: chief operating officer | S-Sale | 2,175 | $20.00 | $44K | Filing |
| 2026-05-22 | Champoux Jennifer | officer: chief operating officer | S-Sale | 2,176 | $19.00 | $41K | Filing |
| 2026-05-21 | Manning Anthony M. | director | S-Sale | 10,000 | $18.01 | $180K | Filing |
| 2026-05-01 | Warmuth Markus | officer: president & ceo | S-Sale | 5,467 | $18.92 | $103K | Filing |
| 2026-04-14 | Warmuth Markus | officer: president & ceo | S-Sale | 8,000 | $17.64 | $141K | Filing |
| 2026-04-09 | Nickson Philip | officer: chief business & legal officer | S-Sale | 5,845 | $17.69 | $103K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 7,692,298 | $186M | — | 2026-06-30 | Filing |
| BlackRock, Inc. | 6,843,087 | $166M | +1,205,403 | 2026-06-30 | Filing |
| TCG Crossover Management, LLC | 4,622,151 | $112M | — | 2026-06-30 | Filing |
| Vestal Point Capital, LP | 4,600,000 | $111M | +996,535 | 2026-06-30 | Filing |
| BVF INC/IL | 4,460,886 | $108M | — | 2026-06-30 | Filing |
| BAKER BROS. ADVISORS LP | 4,345,736 | $105M | — | 2026-06-30 | Filing |
| STATE STREET CORP | 3,731,416 | $90M | +377,436 | 2026-06-30 | Filing |
| MONTANOVA CAPITAL, LLC | 3,549,539 | $86M | -677,270 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,412,927 | $83M | +312,682 | 2026-06-30 | Filing |
| Versant Venture Management, LLC | 3,180,780 | $77M | — | 2026-06-30 | Filing |
| BRAIDWELL LP | 2,451,562 | $59M | -755,012 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,864,113 | $45M | +323,301 | 2026-06-30 | Filing |
| AMERICAN CENTURY COMPANIES INC | 1,622,846 | $39M | -1,186,801 | 2026-06-30 | Filing |
| MARSHALL WACE, LLP | 1,593,600 | $39M | +160,448 | 2026-06-30 | Filing |
| Aisling Capital Management LP | 1,555,664 | $38M | — | 2026-06-30 | Filing |
| Bellevue Group AG | 1,190,000 | $29M | -60,000 | 2026-06-30 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 1,177,488 | $28M | +136,116 | 2026-06-30 | Filing |
| MPM BIOIMPACT LLC | 1,161,081 | $28M | -15,847 | 2026-06-30 | Filing |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,108,295 | $27M | -893,745 | 2026-06-30 | Filing |
| Jupiter Topco LLC | 1,072,494 | $26M | +1,072,494 | 2026-06-30 | Filing |